DAVID BUTTERS
- Type
- Physician · Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Psychiatry
- Where
- LAYTON, UT
- NPI
- 1932272598
- Received
- $189,239 in 950 records, 2019 to 2025
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 38 | $25,063 |
| 2024 | General payment | 37 | $27,999 |
| 2023 | General payment | 197 | $62,272 |
| 2022 | General payment | 179 | $16,405 |
| 2021 | General payment | 188 | $18,110 |
| 2020 | General payment | 116 | $15,676 |
| 2019 | General payment | 195 | $23,712 |
By company
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 111 | $146,461 |
| Food and Beverage | 776 | $13,444 |
| Consulting Fee | 10 | $11,775 |
| Honoraria | 2 | $8,925 |
| Travel and Lodging | 46 | $7,205 |
| Compensation for serving as faculty or as a speaker for a medical education program | 1 | $1,275 |
| Education | 4 | $153 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-10-23 | PFIZER INC. | $75 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-10-14 | ABBVIE INC. | $110 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-08-14 | ABBVIE INC. | $1,875 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-08-11 | ABBVIE INC. | $26 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-07-24 | ABBVIE INC. | $2,625 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-07-24 | ABBVIE INC. | $1,875 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-07-24 | ABBVIE INC. | $1,875 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-07-24 | ABBVIE INC. | $1,875 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-07-24 | ABBVIE INC. | $375 | Consulting Fee | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-07-17 | ABBVIE INC. | $1,875 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-07-17 | ABBVIE INC. | $34 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-07-10 | ABBVIE INC. | $710 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-07-10 | ABBVIE INC. | $386 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-07-10 | ABBVIE INC. | $76 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-07-10 | ABBVIE INC. | $33 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-07-10 | ABBVIE INC. | $16 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-07-10 | ABBVIE INC. | $16 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-07-09 | ABBVIE INC. | $85 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-07-09 | ABBVIE INC. | $28 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-07-01 | AstraZeneca Pharmaceuticals LP | $250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | AIRSUPRA Drug, Respiratory | 2025 | |
| 2025-07-01 | AstraZeneca Pharmaceuticals LP | $250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | AIRSUPRA Drug, Respiratory | 2025 | |
| 2025-06-11 | ABBVIE INC. | $100 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-05-20 | PFIZER INC. | $54 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-04-03 | Axsome Therapeutics, Inc. | $7,650 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-03-15 | Axsome Therapeutics, Inc. | $597 | Travel and Lodging | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-03-15 | Axsome Therapeutics, Inc. | $234 | Travel and Lodging | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-03-15 | Axsome Therapeutics, Inc. | $125 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-03-15 | Axsome Therapeutics, Inc. | $78 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-03-15 | Axsome Therapeutics, Inc. | $60 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-03-15 | Axsome Therapeutics, Inc. | $48 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-03-15 | Axsome Therapeutics, Inc. | $45 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-03-15 | Axsome Therapeutics, Inc. | $32 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-03-15 | Axsome Therapeutics, Inc. | $29 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-03-15 | Axsome Therapeutics, Inc. | $26 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-02-26 | Axsome Therapeutics, Inc. | $102 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-02-10 | ABBVIE INC. | $106 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-02-03 | Axsome Therapeutics, Inc. | $20 | Food and Beverage | In-kind items and services | Sunosi Drug, Neurology | 2025 | |
| 2025-02-01 | Axsome Therapeutics, Inc. | $1,275 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2024-11-15 | Axsome Therapeutics, Inc. | $1,275 | Consulting Fee | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2024 | |
| 2024-11-13 | IDORSIA PHARMACEUTICALS US INC | $98 | Food and Beverage | In-kind items and services | QUVIVIQ Drug, Insomnia | 2024 | |
| 2024-11-06 | ABBVIE INC. | $101 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-11-01 | Axsome Therapeutics, Inc. | $1,275 | Consulting Fee | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2024 | |
| 2024-10-30 | Axsome Therapeutics, Inc. | $1,275 | Consulting Fee | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2024 | |
| 2024-10-25 | Axsome Therapeutics, Inc. | $1,275 | Consulting Fee | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2024 | |
| 2024-10-22 | Exact Sciences Corporation | $13 | Food and Beverage | In-kind items and services | Cologuard Collection Kit Device, Oncology | 2024 | |
| 2024-10-11 | Axsome Therapeutics, Inc. | $1,275 | Consulting Fee | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2024 | |
| 2024-08-16 | Axsome Therapeutics, Inc. | $1,275 | Consulting Fee | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2024 | |
| 2024-08-15 | Lilly USA, LLC | $74 | Food and Beverage | Cash or cash equivalent | MOUNJARO Drug, Diabetes | 2024 | |
| 2024-08-14 | ABBVIE INC. | $79 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-08-07 | Otsuka America Pharmaceutical, Inc. | $789 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-07-30 | Axsome Therapeutics, Inc. | $1,275 | Consulting Fee | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2024 | |
| 2024-07-29 | Axsome Therapeutics, Inc. | $1,275 | Consulting Fee | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2024 | |
| 2024-07-02 | ABBVIE INC. | $1,375 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-06-05 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-05-23 | AstraZeneca Pharmaceuticals LP | $2,700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | AIRSUPRA Drug, Respiratory | 2024 | |
| 2024-05-23 | AstraZeneca Pharmaceuticals LP | $2,400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | AIRSUPRA Drug, Respiratory | 2024 | |
| 2024-05-17 | Axsome Therapeutics, Inc. | $1,275 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2024 | |
| 2024-05-17 | AstraZeneca Pharmaceuticals LP | $149 | Travel and Lodging | In-kind items and services | AIRSUPRA Drug, Respiratory | 2024 | |
| 2024-05-16 | AstraZeneca Pharmaceuticals LP | $263 | Travel and Lodging | In-kind items and services | AIRSUPRA Drug, Respiratory | 2024 | |
| 2024-05-16 | AstraZeneca Pharmaceuticals LP | $126 | Travel and Lodging | In-kind items and services | AIRSUPRA Drug, Respiratory | 2024 | |
| 2024-05-16 | AstraZeneca Pharmaceuticals LP | $125 | Food and Beverage | In-kind items and services | AIRSUPRA Drug, Respiratory | 2024 | |
| 2024-05-16 | AstraZeneca Pharmaceuticals LP | $27 | Food and Beverage | In-kind items and services | AIRSUPRA Drug, Respiratory | 2024 | |
| 2024-05-16 | AstraZeneca Pharmaceuticals LP | $17 | Food and Beverage | In-kind items and services | AIRSUPRA Drug, Respiratory | 2024 | |
| 2024-05-08 | Otsuka America Pharmaceutical, Inc. | $256 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-05-02 | Axsome Therapeutics, Inc. | $59 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2024 | |
| 2024-04-11 | Novo Nordisk Inc | $57 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2024 | |
| 2024-03-19 | ABBVIE INC. | $1,375 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-03-08 | AstraZeneca Pharmaceuticals LP | $1,700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | AIRSUPRA Drug, Respiratory | 2024 | |
| 2024-02-21 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-02-07 | AstraZeneca Pharmaceuticals LP | $1,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | AIRSUPRA Drug, Respiratory | 2024 | |
| 2024-02-07 | AstraZeneca Pharmaceuticals LP | $1,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | AIRSUPRA Drug, Respiratory | 2024 | |
| 2024-02-06 | ABBVIE INC. | $1,375 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-02-01 | AstraZeneca Pharmaceuticals LP | $300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | AIRSUPRA Drug, Respiratory | 2024 | |
| 2024-01-26 | AstraZeneca Pharmaceuticals LP | $1,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | AIRSUPRA Drug, Respiratory | 2024 | |
| 2024-01-24 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2023-12-29 | ABBVIE INC. | $1,375 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-12-22 | ABBVIE INC. | $1,375 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-12-21 | ABBVIE INC. | $1,925 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-12-19 | ABBVIE INC. | $27 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-12-19 | ABBVIE INC. | $22 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-12-15 | ABBVIE INC. | $251 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-12-15 | ABBVIE INC. | $28 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-12-15 | ABBVIE INC. | $12 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-12-12 | ABBVIE INC. | $53 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-12-12 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-11-28 | ABBVIE INC. | $1,375 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-11-15 | Otsuka America Pharmaceutical, Inc. | $1,430 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2023 | |
| 2023-11-15 | Otsuka America Pharmaceutical, Inc. | $1,430 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2023 | |
| 2023-11-10 | Otsuka America Pharmaceutical, Inc. | $1,430 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2023 | |
| 2023-11-07 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-11-01 | Otsuka America Pharmaceutical, Inc. | $15 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2023 | |
| 2023-10-30 | Otsuka America Pharmaceutical, Inc. | $24 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2023 | |
| 2023-10-27 | Otsuka America Pharmaceutical, Inc. | $1,430 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2023 | |
| 2023-10-27 | Otsuka America Pharmaceutical, Inc. | $1,430 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2023 | |
| 2023-10-26 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $60 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-10-26 | Otsuka America Pharmaceutical, Inc. | $18 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2023 | |
| 2023-10-24 | Otsuka America Pharmaceutical, Inc. | $21 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2023 | |
| 2023-10-23 | AstraZeneca Pharmaceuticals LP | $2,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | AIRSUPRA Drug, Respiratory | 2023 | |
| 2023-10-18 | Astellas Pharma US Inc | $58 | Food and Beverage | In-kind items and services | Veozah Drug, Biological | 2023 | |
| 2023-10-18 | Otsuka America Pharmaceutical, Inc. | $16 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2023 | |
| 2023-10-11 | Otsuka America Pharmaceutical, Inc. | $1,430 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2023 | |
| 2023-10-03 | Otsuka America Pharmaceutical, Inc. | $23 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2023 | |
| 2023-09-30 | AstraZeneca Pharmaceuticals LP | $76 | Food and Beverage | In-kind items and services | AIRSUPRA Drug, Respiratory | 2023 | |
| 2023-09-30 | AstraZeneca Pharmaceuticals LP | $60 | Food and Beverage | In-kind items and services | AIRSUPRA Drug, Respiratory | 2023 | |
| 2023-09-29 | AstraZeneca Pharmaceuticals LP | $707 | Travel and Lodging | In-kind items and services | AIRSUPRA Drug, Respiratory | 2023 | |
| 2023-09-29 | AstraZeneca Pharmaceuticals LP | $265 | Travel and Lodging | In-kind items and services | AIRSUPRA Drug, Respiratory | 2023 | |
| 2023-09-29 | AstraZeneca Pharmaceuticals LP | $134 | Food and Beverage | In-kind items and services | AIRSUPRA Drug, Respiratory | 2023 | |
| 2023-09-28 | AstraZeneca Pharmaceuticals LP | $86 | Food and Beverage | In-kind items and services | AIRSUPRA Drug, Respiratory | 2023 | |
| 2023-09-28 | AstraZeneca Pharmaceuticals LP | $70 | Travel and Lodging | In-kind items and services | AIRSUPRA Drug, Respiratory | 2023 | |
| 2023-09-12 | PFIZER INC. | $66 | Food and Beverage | In-kind items and services | 2023 | ||
| 2023-09-06 | ABBVIE INC. | $1,375 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-08-29 | ABBVIE INC. | $1,375 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-08-28 | Otsuka Pharmaceutical Development & Commercialization, Inc. | $66 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2023 | |
| 2023-08-22 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-08-17 | AstraZeneca Pharmaceuticals LP | $102 | Food and Beverage | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2023 | |
| 2023-08-07 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-07-27 | Boehringer Ingelheim Pharmaceuticals, Inc. | $20 | Food and Beverage | In-kind items and services | TRADJENTA Drug, DIABETES | 2023 | |
| 2023-07-26 | Organon Llc | $11 | Food and Beverage | In-kind items and services | NEXPLANON Drug, ETONOGESTREL | 2023 | |
| 2023-07-20 | AstraZeneca Pharmaceuticals LP | $125 | Food and Beverage | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2023 | |
| 2023-07-20 | ABBVIE INC. | $2 | Food and Beverage | In-kind items and services | VIBERZI Drug, GASTROENTEROLOGY | 2023 | |
| 2023-07-18 | Astellas Pharma US Inc | $13 | Food and Beverage | In-kind items and services | Veozah Drug, Biological | 2023 | |
| 2023-07-17 | Amneal Pharmaceuticals LLC | $16 | Food and Beverage | In-kind items and services | RYTARY Drug, NEUROLOGY | 2023 | |
| 2023-07-13 | Amgen Inc. | $14 | Food and Beverage | In-kind items and services | Otezla Drug, Inflammation | 2023 | |
| 2023-07-13 | Sumitomo Pharma America, Inc. | $3 | Food and Beverage | In-kind items and services | GEMTESA Drug, UROLOGY | 2023 | |
| 2023-07-12 | Otsuka America Pharmaceutical, Inc. | $832 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2023 | |
| 2023-07-12 | Astellas Pharma US Inc | $16 | Food and Beverage | In-kind items and services | Veozah Drug, Biological | 2023 | |
| 2023-07-10 | ABBVIE INC. | $2 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-07-10 | ABBVIE INC. | $1 | Food and Beverage | In-kind items and services | VIBERZI Drug, GASTROENTEROLOGY | 2023 | |
| 2023-07-07 | Otsuka America Pharmaceutical, Inc. | $256 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2023 | |
| 2023-07-06 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $16 | Food and Beverage | In-kind items and services | XIFAXAN Drug, Gastroenterology | 2023 | |
| 2023-07-06 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2023 | |
| 2023-07-06 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2023 | |
| 2023-07-06 | ABBVIE INC. | $3 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-07-03 | GlaxoSmithKline, LLC. | $16 | Food and Beverage | In-kind items and services | AREXVY Drug, RESPIRATORY | 2023 | |
| 2023-06-28 | ABBVIE INC. | $5 | Food and Beverage | In-kind items and services | VIBERZI Drug, GASTROENTEROLOGY | 2023 | |
| 2023-06-27 | ABBVIE INC. | $1,375 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-06-27 | Lilly USA, LLC | $14 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2023 | |
| 2023-06-21 | ABBVIE INC. | $1,375 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-06-21 | ABBVIE INC. | $32 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2023 | |
| 2023-06-21 | ABBVIE INC. | $32 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2023 | |
| 2023-06-21 | Alkermes, Inc. | $15 | Food and Beverage | In-kind items and services | Vivitrol Drug, CNS | 2023 | |
| 2023-06-21 | ABBVIE INC. | $2 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-06-20 | Amgen Inc. | $18 | Food and Beverage | In-kind items and services | Otezla Drug, Inflammation | 2023 | |
| 2023-06-15 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $124 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-06-15 | Astellas Pharma US Inc | $17 | Food and Beverage | In-kind items and services | Veozah Drug, Biological | 2023 | |
| 2023-06-14 | Alkermes, Inc. | $16 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2023 | |
| 2023-06-13 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-06-09 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-06-09 | GlaxoSmithKline, LLC. | $17 | Food and Beverage | In-kind items and services | AREXVY Drug, RESPIRATORY | 2023 | |
| 2023-06-08 | Sumitomo Pharma America, Inc. | $17 | Food and Beverage | In-kind items and services | GEMTESA Drug, UROLOGY | 2023 | |
| 2023-06-08 | IDORSIA PHARMACEUTICALS US INC | $8 | Food and Beverage | In-kind items and services | QUVIVIQ Drug, INSOMNIA | 2023 | |
| 2023-06-02 | IDORSIA PHARMACEUTICALS US INC | $60 | Travel and Lodging | Cash or cash equivalent | QUVIVIQ Drug, INSOMNIA | 2023 | |
| 2023-06-01 | IDORSIA PHARMACEUTICALS US INC | $55 | Travel and Lodging | Cash or cash equivalent | QUVIVIQ Drug, INSOMNIA | 2023 | |
| 2023-05-31 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-05-31 | Otsuka America Pharmaceutical, Inc. | $17 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2023 | |
| 2023-05-31 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $15 | Food and Beverage | In-kind items and services | XIFAXAN Drug, Gastroenterology | 2023 | |
| 2023-05-30 | Axsome Therapeutics, Inc. | $18 | Food and Beverage | In-kind items and services | Sunosi Drug, Neurology | 2023 | |
| 2023-05-26 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-05-25 | IDORSIA PHARMACEUTICALS US INC | $1,338 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | QUVIVIQ Drug, INSOMNIA | 2023 | |
| 2023-05-25 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-05-24 | IDORSIA PHARMACEUTICALS US INC | $18 | Food and Beverage | In-kind items and services | QUVIVIQ Drug, INSOMNIA | 2023 | |
| 2023-05-23 | ABBVIE INC. | $1,925 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-05-23 | ABBVIE INC. | $1,375 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-05-18 | Lundbeck LLC | $15 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2023 | |
| 2023-05-16 | Amgen Inc. | $16 | Food and Beverage | In-kind items and services | Otezla Drug, Inflammation | 2023 | |
| 2023-05-16 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $13 | Food and Beverage | In-kind items and services | XIFAXAN Drug, Gastroenterology | 2023 | |
| 2023-05-12 | IDORSIA PHARMACEUTICALS US INC | $1,338 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | QUVIVIQ Drug, INSOMNIA | 2023 | |
| 2023-05-11 | ABBVIE INC. | $94 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-05-11 | ABBVIE INC. | $20 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-05-09 | ABBVIE INC. | $1,925 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-05-09 | Takeda Pharmaceuticals U.S.A., Inc. | $13 | Food and Beverage | In-kind items and services | GATTEX Drug, INTERNAL MEDICINE | 2023 | |
| 2023-05-05 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-05-04 | Sumitomo Pharma America, Inc. | $16 | Food and Beverage | In-kind items and services | GEMTESA Drug, UROLOGY | 2023 | |
| 2023-05-01 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-04-28 | IDORSIA PHARMACEUTICALS US INC | $1,338 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | QUVIVIQ Drug, INSOMNIA | 2023 | |
| 2023-04-26 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $14 | Food and Beverage | In-kind items and services | XIFAXAN Drug, Gastroenterology | 2023 | |
| 2023-04-26 | IDORSIA PHARMACEUTICALS US INC | $12 | Food and Beverage | In-kind items and services | QUVIVIQ Drug, INSOMNIA | 2023 | |
| 2023-04-25 | ABBVIE INC. | $1,925 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-04-25 | ABBVIE INC. | $1,375 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-04-25 | ABBVIE INC. | $1,375 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-04-25 | ABBVIE INC. | $1,375 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-04-25 | ABBVIE INC. | $825 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-04-25 | Otsuka America Pharmaceutical, Inc. | $20 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2023 | |
| 2023-04-25 | Organon Llc | $10 | Food and Beverage | In-kind items and services | NEXPLANON Drug, ETONOGESTREL | 2023 | |
| 2023-04-24 | IDORSIA PHARMACEUTICALS US INC | $17 | Food and Beverage | In-kind items and services | QUVIVIQ Drug, INSOMNIA | 2023 | |
| 2023-04-21 | ABBVIE INC. | $112 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-04-20 | IDORSIA PHARMACEUTICALS US INC | $1,102 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | QUVIVIQ Drug, INSOMNIA | 2023 | |
| 2023-04-20 | Boehringer Ingelheim Pharmaceuticals, Inc. | $23 | Food and Beverage | In-kind items and services | TRADJENTA Drug, DIABETES | 2023 | |
| 2023-04-20 | ABBVIE INC. | $2 | Food and Beverage | In-kind items and services | VIBERZI Drug, GASTROENTEROLOGY | 2023 | |
| 2023-04-19 | AstraZeneca Pharmaceuticals LP | $17 | Food and Beverage | In-kind items and services | FLUMIST QUADRIVALENT Biological, Respiratory | 2023 | |
| 2023-04-18 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-04-14 | IDORSIA PHARMACEUTICALS US INC | $19 | Food and Beverage | In-kind items and services | QUVIVIQ Drug, INSOMNIA | 2023 | |
| 2023-04-14 | Novo Nordisk Inc | $13 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2023 | |
| 2023-04-13 | Lundbeck LLC | $13 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2023 | |
| 2023-04-12 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $14 | Food and Beverage | In-kind items and services | XIFAXAN Drug, Gastroenterology | 2023 | |
| 2023-04-11 | Astellas Pharma US Inc | $14 | Food and Beverage | In-kind items and services | Myrbetriq Drug, Urology | 2023 | |
| 2023-04-06 | PFIZER INC. | $19 | Food and Beverage | In-kind items and services | PAXLOVID Drug, INFECTIOUS DISEASES | 2023 | |
| 2023-04-04 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-04-03 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-03-31 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 |
The latest 200 records of 950.
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Layton, UT, county Davis County, UT, state Utah; placed by its city name.
| Measure | Place (city or town) Layton, UT | County Davis County, UT | State Utah |
|---|---|---|---|
| Population B01003 | 83,286 | 370,924 | 3,392,331 |
| Population, 2020 census P1 | 81,773 | 362,679 | 3,271,616 |
| Median age B01002 | 32.3 | 32.5 | 32.0 |
| Under 18 B01001 | 29.0% | 30.1% | 27.8% |
| 65 and over B01001 | 10.8% | 11.0% | 11.9% |
| Households B11001 | 27,779 | 115,919 | 1,124,822 |
| Foreign born B05002 | 6.9% | 5.8% | 8.9% |
| Median household income B19013 | $102,480 | $110,884 | $95,166 |
| Median family income B19113 | $121,078 | $123,351 | $109,675 |
| Per capita income B19301 | $42,444 | $42,483 | $40,873 |
| Poverty rate B17001 | 8.1% | 6.4% | 8.5% |
| Unemployment rate B23025 | 2.8% | 2.7% | 3.6% |
| Civilian labor force B23025 | 44,526 | 189,751 | 1,778,106 |
| Mean commute (minutes) B08013 | 22.9 | 22.9 | 22.1 |
| Bachelor's degree or higher B15003 | 36.6% | 39.3% | 37.7% |
| Housing units B25001 | 29,155 | 120,879 | 1,223,468 |
| Owner-occupied B25003 | 72.5% | 77.3% | 70.2% |
| Renters B25003 | 27.5% | 22.7% | 29.8% |
| Median home value B25077 | $477,700 | $505,500 | $489,400 |
| Median gross rent B25064 | $1,538 | $1,621 | $1,496 |
| White, not Hispanic B03002 | 76.5% | 79.9% | 74.7% |
| Black B03002 | 1.2% | 1.1% | 1.1% |
| Hispanic or Latino B03002 | 15.5% | 11.7% | 15.9% |
| Asian B03002 | 1.9% | 1.9% | 2.4% |
| American Indian and Alaska Native B03002 | 0.1% | 0.3% | 0.6% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Layton, UT.
Comments